IN2012DN01577A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01577A IN2012DN01577A IN1577DEN2012A IN2012DN01577A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A IN 1577DEN2012 A IN1577DEN2012 A IN 1577DEN2012A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A
- Authority
- IN
- India
- Prior art keywords
- relates
- present
- attenuated
- cells
- preparation
- Prior art date
Links
- 241000700605 Viruses Species 0.000 abstract 4
- 241000287828 Gallus gallus Species 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 210000002257 embryonic structure Anatomy 0.000 abstract 2
- 230000002255 enzymatic effect Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24151—Methods of production or purification of viral material
Abstract
The present invention relates to an enzymatic composition for the digestion of chicken embryos intended to the preparation of cells which are used for the production of viruses. The present invention also relates to a method for producing a wild type, an attenuated and/or a recombinant virus comprising a step of preparation of cells from chicken embryos using an enzymatic composition of the invention. The present invention relates to a purified wild type, attenuated and/or recombinant virus obtained and to a pharmaceutical composition, preferably a vaccine, comprising said virus for the treatment and/or the prevention a cancer, an infectious disease and/or an autoimmune disorder, and uses thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09305690 | 2009-07-21 | ||
US26429909P | 2009-11-25 | 2009-11-25 | |
PCT/EP2010/004478 WO2011009613A1 (en) | 2009-07-21 | 2010-07-21 | Enzymatic composition for the digestion of chicken embryos |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01577A true IN2012DN01577A (en) | 2015-06-05 |
Family
ID=43498784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1577DEN2012 IN2012DN01577A (en) | 2009-07-21 | 2010-07-21 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20120190100A1 (en) |
EP (1) | EP2456461A1 (en) |
JP (1) | JP2012533311A (en) |
KR (1) | KR20120089245A (en) |
CN (1) | CN102939100A (en) |
AU (1) | AU2010275764A1 (en) |
CA (1) | CA2768562A1 (en) |
IN (1) | IN2012DN01577A (en) |
MX (1) | MX2012000979A (en) |
RU (1) | RU2012106760A (en) |
SG (1) | SG178090A1 (en) |
TW (1) | TW201109440A (en) |
WO (1) | WO2011009613A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201221641A (en) * | 2010-10-11 | 2012-06-01 | Abbott Lab | Processes for purification of proteins |
JP6282270B2 (en) | 2012-07-09 | 2018-02-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Neutral protease derived from recombinant Paenibacillus polymixer |
CN104818238B (en) * | 2015-03-26 | 2019-12-20 | 四川农业大学 | Chicken intestine epithelial cell separation culture method |
DK3298139T3 (en) * | 2015-05-19 | 2021-10-25 | Scient Protein Laboratories Llc | Method for reducing or inactivating viral and microbial content in the processes of pancreatin production |
US10093916B2 (en) | 2015-05-19 | 2018-10-09 | Scientific Protein Laboratories, Llc | Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin |
CN105316309A (en) * | 2015-12-04 | 2016-02-10 | 广州赛莱拉干细胞科技股份有限公司 | Digestive enzyme composition and preparation method of fibroblasts and feeder layer cells |
CN109957545A (en) * | 2017-12-26 | 2019-07-02 | 江苏艾尔康生物医药科技有限公司 | A method of digestion RPE cell |
US20220347244A1 (en) * | 2018-01-19 | 2022-11-03 | Kolon Life Science, Inc. | Recombinant vaccinia virus and pharmaceutical composition comprising same |
EP3787771A1 (en) * | 2018-04-29 | 2021-03-10 | REGENXBIO Inc. | Scalable clarification process for recombinant aav production |
CN109943520B (en) * | 2019-03-08 | 2023-06-23 | 中国人民解放军军事科学院军事医学研究院 | Method for obtaining sweat gland organoids by separating and culturing sweat gland cells and application thereof |
CN111117947B (en) * | 2020-01-09 | 2022-03-08 | 电子科技大学 | Rapid separation method of cyprinid liver-like cells |
CN112458040B (en) * | 2020-12-23 | 2022-07-05 | 四川农业大学 | Isolation culture method of rumen epithelial cells of adult yaks |
CN113136412A (en) * | 2021-04-22 | 2021-07-20 | 浙江珂瑞康生物医疗科技有限公司 | Biological load determination treatment liquid for biomedical material containing soluble protein |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4072565A (en) * | 1974-11-04 | 1978-02-07 | The Dow Chemical Company | Production of viruses in tissue culture without use of serum |
US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
FR2643817B1 (en) | 1989-03-06 | 1993-12-17 | Transgene Sa | PHARMACEUTICAL COMPOSITION, USEFUL AS A PREVENTIVE OR CURATIVE AGAINST TUMORS INDUCED BY PAPILLOMAVIRUS |
GB8705477D0 (en) | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
GB9001641D0 (en) | 1990-01-24 | 1990-03-21 | Imp Cancer Res Tech | Compounds |
FR2668064B1 (en) | 1990-10-23 | 1994-12-16 | Transgene Sa | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF MALIGNANT TUMOR. |
ATE322547T1 (en) | 1993-06-10 | 2006-04-15 | Genetic Therapy Inc | ADENOVIRAL VECTORS FOR THE TREATMENT OF HEMOPHILIA |
FR2710536B1 (en) | 1993-09-29 | 1995-12-22 | Transgene Sa | Anti-cancer use of a viral vector comprising a gene which modulates the immune and / or inflammatory response. |
FR2751879B1 (en) | 1996-07-30 | 1998-10-30 | Transgene Sa | PHARMACEUTICAL COMPOSITION AGAINST TUMORS AND PAPILLOMAVIRUS INFECTIONS |
FR2766091A1 (en) | 1997-07-18 | 1999-01-22 | Transgene Sa | ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION |
FR2777570A1 (en) | 1998-04-17 | 1999-10-22 | Transgene Sa | Novel mutant enzyme and related fusion proteins, useful for gene therapy of cancer, by prodrug activation |
SI1434858T2 (en) * | 2002-09-05 | 2019-05-31 | Bavarian Nordic A/S | Method for the amplification of a poxvirus under serum free conditions |
FR2855758B1 (en) | 2003-06-05 | 2005-07-22 | Biomerieux Sa | COMPOSITION COMPRISING NS3 / NS4 POLYPROTEIN AND HCV NS5B POLYPEPTIDE, EXPRESSION VECTORS INCLUDING THE CORRESPONDING NUCLEIC SEQUENCES AND THEIR USE IN THERAPEUTICS |
ATE405654T1 (en) | 2003-07-21 | 2008-09-15 | Transgene Sa | POLYPEPTIDE WITH IMPROVED CYTOSINE DEEAMINASE ACTIVITY |
AU2003267841A1 (en) * | 2003-09-29 | 2005-04-14 | Seong Jun Yoon | Highly bioactive and productive chicken embryo extract and method for preparation thereof |
MX2007001772A (en) * | 2004-08-13 | 2007-07-11 | Univ Georgia Res Found | Compositions and methods for self-renewal and differentiation in human embryonic stem cells. |
EP1807508A4 (en) * | 2004-11-05 | 2008-03-12 | Us Gov Health & Human Serv | Methods for preparing cells and viruses |
NZ563603A (en) | 2005-04-29 | 2010-10-29 | Innovative Dairy Products Pty | A method for producing stem cells or stem cell-like cells from mammalian embryos |
BRPI0710242A2 (en) | 2006-04-21 | 2011-08-09 | Transgene Sa | use of a composition |
NZ573437A (en) | 2006-06-20 | 2012-02-24 | Transgene Sa | Process for producing poxviruses and poxvirus compositions |
GB0613756D0 (en) * | 2006-07-12 | 2006-08-23 | Univ Sheffield | Cell culture medium |
-
2010
- 2010-07-21 MX MX2012000979A patent/MX2012000979A/en not_active Application Discontinuation
- 2010-07-21 EP EP20100735215 patent/EP2456461A1/en not_active Withdrawn
- 2010-07-21 IN IN1577DEN2012 patent/IN2012DN01577A/en unknown
- 2010-07-21 TW TW99124030A patent/TW201109440A/en unknown
- 2010-07-21 CA CA2768562A patent/CA2768562A1/en not_active Abandoned
- 2010-07-21 JP JP2012520954A patent/JP2012533311A/en not_active Withdrawn
- 2010-07-21 CN CN2010800583217A patent/CN102939100A/en active Pending
- 2010-07-21 KR KR1020127004441A patent/KR20120089245A/en not_active Application Discontinuation
- 2010-07-21 SG SG2012004883A patent/SG178090A1/en unknown
- 2010-07-21 US US13/386,168 patent/US20120190100A1/en not_active Abandoned
- 2010-07-21 RU RU2012106760/10A patent/RU2012106760A/en not_active Application Discontinuation
- 2010-07-21 WO PCT/EP2010/004478 patent/WO2011009613A1/en active Application Filing
- 2010-07-21 AU AU2010275764A patent/AU2010275764A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2012533311A (en) | 2012-12-27 |
KR20120089245A (en) | 2012-08-09 |
CA2768562A1 (en) | 2011-01-27 |
TW201109440A (en) | 2011-03-16 |
EP2456461A1 (en) | 2012-05-30 |
SG178090A1 (en) | 2012-03-29 |
WO2011009613A1 (en) | 2011-01-27 |
RU2012106760A (en) | 2013-08-27 |
CN102939100A (en) | 2013-02-20 |
AU2010275764A2 (en) | 2012-03-15 |
AU2010275764A1 (en) | 2012-03-15 |
US20120190100A1 (en) | 2012-07-26 |
MX2012000979A (en) | 2012-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN01577A (en) | ||
BR112013011194A2 (en) | rabies virus-like glycoprotein particles (vlps). | |
WO2011000566A3 (en) | Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections | |
PH12015501953A1 (en) | Substituted nucleotide analogs | |
CR20110641A (en) | METHOD FOR THE PRODUCTION AND PURIFICATION OF ORTHOPOXVIRUS | |
NZ629582A (en) | Production of fmdv-resistant livestock by allele substitution | |
CY1114356T1 (en) | SUSPENSION VIRUS INHIBITIONS C | |
TW200636070A (en) | Rescue of influenza virus | |
MXPA06013411A (en) | Process for the production of an influenza vaccine. | |
EA201490853A1 (en) | ANTI-VIRUS COMPOUNDS | |
PE20150356A1 (en) | VACCINE COMPOSITIONS FOR THE PREVENTION AGAINST INFECTION BY DENGUE VIRUS | |
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
MX349119B (en) | Inactivated dengue virus vaccine. | |
SG179082A1 (en) | Method for the preparation of an influenza virus | |
NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
WO2011007339A3 (en) | Chimeric foot and mouth disease viruses | |
WO2009080806A3 (en) | Modified influenza virus | |
WO2009135199A3 (en) | Vaccine compositions and methods | |
WO2013058484A3 (en) | Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same | |
MX339731B (en) | Infectious bronchitis vaccines derived from ib-qx-like strains. | |
WO2009126308A3 (en) | Compositions and methods for vaccine and virus production | |
MX2011002309A (en) | Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use. | |
WO2009152519A3 (en) | Novel antiviral peptides against influenza virus | |
IN2011KN02819A (en) | ||
WO2014008475A3 (en) | Compositions and methods related to viral vaccines |